Tag Archives: Cholesterol Lowering Drugs Market Forecast

The cholesterol-lowering drugs market is anticipated to expand at a compound annual growth rate (CAGR) of 3.3% from 2024 to 2032. This growth will be propelled by rising cardiovascular health awareness, developments in PCSK9 inhibitors, and the increasing incidence of lifestyle-related ailments. Notwithstanding the obstacles posed by medication adherence, the market exhibited fortitude. Pharmaceutical companies involved in the production of ...